Medical devices, healthcare technology and the business of care
510(k) clearance · K261811

PRIMED Chemotherapy Drug Tested Gowns (PM4-99450: PRIMED Chemotherapy Drug Tested Isolation Gown, Purple, AAMI Level 2; PM4-99460: PRIMED Chemotherapy Drug Tested Isolation Gown, Blue, AAMI Level 3)

PRIMED Medical Products, Inc. · Decision date Sep 1, 2026

MEDTECHLEDGER EXPLANATIONK261811

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-01 for K261811, a traditional 510(k) received 06/01/2026 from PRIMED Medical Products, Inc. of Edmonton, Canada. The submission covers PRIMED Chemotherapy Drug Tested Gowns in two configurations: PM4-99450, a purple isolation gown designated AAMI Level 2, and PM4-99460, a blue isolation gown designated AAMI Level 3. The device classification is medical gowns with chemotherapy labeling claims tested for use with chemotherapy drugs, under regulation 878.4040, product code QSO, with FYC as a subsequent product code.

SESE means FDA found the submission substantially equivalent to a legally marketed predicate, which is a clearance rather than PMA approval. The review panel was General Hospital and the regulation medical specialty is General, Plastic Surgery; the record states the submission was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. The public record does not identify the predicate device, summarize the testing or performance data, or describe labeling content, so the basis for the equivalence finding and any chemotherapy-specific performance results remain unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 1, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261811
Regulatory pathway
510(k) premarket notification
Product code
QSO
Decision code
SESE
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Medical Gowns With Chemotherapy Labeling Claims - Tested For Use With Chemotherapy Drugs.

Product code
QSO
FDA device class
2

FDA decision timeline

  1. K261811 received

    Application receipt date recorded by FDA.

  2. K261811 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code QSO

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

PRIMED Medical Products, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Edmonton

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records